HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroshi Kobayashi Selected Research
Hiroshi Kobayashi Research Topics
Disease
112
Neoplasms (Cancer)
10/2022 - 08/2002
47
Ovarian Neoplasms (Ovarian Cancer)
09/2022 - 08/2002
45
Neoplasm Metastasis (Metastasis)
06/2022 - 03/2003
39
Endometriosis
12/2021 - 01/2009
27
Carcinoma (Carcinomatosis)
09/2021 - 04/2003
25
Inflammation (Inflammations)
07/2022 - 05/2003
23
Carcinogenesis
03/2022 - 07/2002
15
Hemorrhage
12/2021 - 10/2008
11
Sarcoma (Soft Tissue Sarcoma)
05/2022 - 09/2004
11
Mucopolysaccharidosis II (Hunter Syndrome)
05/2021 - 09/2012
10
Glycogen Storage Disease Type II (Pompe's Disease)
01/2017 - 05/2010
9
Ovarian Epithelial Carcinoma
02/2022 - 08/2012
9
Pre-Eclampsia (Preeclampsia)
01/2020 - 09/2009
8
Pain (Aches)
01/2021 - 09/2010
7
Hypoxia (Hypoxemia)
01/2022 - 09/2009
7
Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2019 - 06/2010
7
Endometrial Neoplasms (Endometrial Cancer)
06/2018 - 11/2002
7
Hypersensitivity (Allergy)
01/2016 - 05/2009
6
Adenomyosis
07/2022 - 03/2013
6
Cysts
12/2021 - 07/2012
6
Lysosomal Storage Diseases (Lysosomal Storage Disease)
05/2021 - 05/2014
6
Mesothelioma
03/2013 - 11/2010
6
Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2012 - 05/2003
5
Wounds and Injuries (Trauma)
10/2022 - 10/2009
5
Residual Neoplasm
01/2022 - 03/2005
5
Rheumatoid Arthritis
01/2022 - 07/2003
5
Fibrosis (Cirrhosis)
01/2020 - 05/2003
5
Osteoarthritis
01/2020 - 10/2013
5
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2017 - 04/2012
5
Menstruation Disturbances
11/2017 - 08/2009
5
Premature Obstetric Labor (Premature Labor)
07/2016 - 01/2011
5
Hypertension (High Blood Pressure)
04/2014 - 09/2007
5
Chondrosarcoma
11/2005 - 03/2002
4
Fabry Disease (Fabry's Disease)
06/2022 - 05/2011
4
Stomach Neoplasms (Stomach Cancer)
03/2022 - 02/2010
4
Ascites
01/2022 - 05/2004
4
Infections
06/2021 - 05/2009
4
Spontaneous Fractures (Pathological Fracture)
10/2020 - 09/2010
4
Lymphatic Metastasis
01/2020 - 09/2010
4
Lung Neoplasms (Lung Cancer)
01/2020 - 08/2005
4
Premature Birth (Birth, Premature)
01/2020 - 10/2008
4
Mucopolysaccharidosis I (Hurler Syndrome)
01/2018 - 05/2005
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2017 - 03/2009
Drug/Important Bio-Agent (IBA)
39
Proteins (Proteins, Gene)
FDA Link
09/2022 - 08/2002
23
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2022 - 03/2002
22
Iron
IBA
12/2021 - 10/2008
18
Cytokines
IBA
01/2021 - 04/2003
17
Protease Inhibitors (Protease Inhibitor)
IBA
01/2013 - 03/2002
14
Glycosaminoglycans
IBA
05/2021 - 05/2005
13
Biomarkers (Surrogate Marker)
IBA
02/2022 - 03/2005
13
Heme (Haem)
IBA
12/2021 - 10/2008
13
Messenger RNA (mRNA)
IBA
07/2018 - 08/2002
11
Enzymes
IBA
10/2022 - 09/2002
11
Antioxidants
IBA
03/2022 - 03/2006
10
Glucosidases
IBA
10/2022 - 11/2011
10
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2022 - 08/2009
10
Biological Products
IBA
01/2021 - 05/2003
10
Transcription Factors (Transcription Factor)
IBA
04/2018 - 04/2003
10
Ligands
IBA
09/2017 - 08/2009
9
Acids
IBA
10/2022 - 11/2011
9
Pharmaceutical Preparations
IBA
01/2022 - 08/2009
9
Phosphotransferases (Kinase)
IBA
12/2021 - 12/2002
8
Urokinase Plasminogen Activator Receptors
IBA
01/2022 - 08/2002
8
ErbB Receptors (EGF Receptor)
IBA
01/2020 - 12/2010
8
Peptide Hydrolases (Proteases)
FDA Link
08/2015 - 04/2003
7
tissue-factor-pathway inhibitor 2 (PP5)
IBA
09/2022 - 08/2015
7
Hemoglobins (Hemoglobin)
IBA
01/2021 - 01/2015
7
DNA (Deoxyribonucleic Acid)
IBA
04/2019 - 06/2010
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2011 - 11/2004
6
Transforming Growth Factor beta1 (TGF beta 1)
IBA
11/2005 - 07/2003
5
Antigens
IBA
09/2022 - 08/2015
5
fibrin fragment D (D-dimer)
IBA
02/2022 - 04/2012
5
Hormones (Hormone)
IBA
12/2021 - 01/2011
5
Platinum
IBA
11/2021 - 02/2012
5
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2018 - 08/2005
5
Lipopolysaccharides
IBA
01/2016 - 03/2005
5
Hepatocyte Nuclear Factors
IBA
11/2013 - 10/2011
4
Estrogens (Estrogen)
FDA Link
07/2022 - 10/2011
4
Plasminogen Inactivators
IBA
01/2022 - 07/2003
4
C-Reactive Protein
IBA
06/2021 - 01/2015
4
Estrogen Receptors
IBA
03/2021 - 08/2002
4
RNA (Ribonucleic Acid)
IBA
01/2021 - 04/2012
4
Tyrosine Kinase Inhibitors
IBA
01/2021 - 04/2014
4
Indicators and Reagents (Reagents)
IBA
01/2021 - 09/2004
4
Therapeutic Uses
IBA
12/2020 - 01/2013
4
Dihydrotachysterol (AT 10)
IBA
05/2020 - 08/2005
4
Hepatocyte Nuclear Factor 1-beta
IBA
05/2019 - 04/2009
4
Peptides (Polypeptides)
IBA
09/2017 - 09/2009
4
Glycogen
IBA
01/2017 - 05/2010
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2016 - 09/2010
Therapy/Procedure
48
Therapeutics
07/2022 - 02/2004
29
Drug Therapy (Chemotherapy)
06/2022 - 09/2004
17
Radiotherapy
05/2021 - 09/2010
12
Enzyme Replacement Therapy
12/2020 - 05/2010
9
Hysterectomy
01/2020 - 10/2007
8
Adjuvant Chemotherapy
05/2022 - 09/2004
6
Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 05/2011
5
Laparotomy
05/2022 - 04/2013
5
Curettage
12/2021 - 12/2017
4
Gastrectomy
03/2022 - 02/2010